Healthcare provider profile · identity verified

Rong Wang, M.D.

Internal Medicine · CORVALLIS, OR · NPI 1174574677

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	1037	280
Atorvastatin Calcium	Atorvastatin Calcium	776	221
Losartan Potassium	Losartan Potassium	594	180
Gabapentin	Gabapentin	590	143
Amlodipine Besylate	Amlodipine Besylate	470	147
Metoprolol Succinate	Metoprolol Succinate	407	124
Lisinopril	Lisinopril	386	121
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	366	77
Simvastatin	Simvastatin	268	85
Omeprazole	Omeprazole	266	84
Rosuvastatin Calcium	Rosuvastatin Calcium	234	75
Fenofibrate	Fenofibrate	232	62
Eliquis	Apixaban	230	69
Sertraline Hcl	Sertraline Hcl	227	66
Hydrochlorothiazide	Hydrochlorothiazide	226	64
Metformin Hcl Er	Metformin Hcl	222	72
Alendronate Sodium	Alendronate Sodium	220	63
Metoprolol Tartrate	Metoprolol Tartrate	183	50
Pantoprazole Sodium	Pantoprazole Sodium	180	58
Potassium Chloride	Potassium Chloride	166	44
Pravastatin Sodium	Pravastatin Sodium	163	49
Alprazolam	Alprazolam	155	61
Escitalopram Oxalate	Escitalopram Oxalate	152	47
Zolpidem Tartrate	Zolpidem Tartrate	145	36
Tramadol Hcl	Tramadol Hcl	144	48
Furosemide	Furosemide	137	40
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	137	36
Warfarin Sodium	Warfarin Sodium	131	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	127	49
Trazodone Hcl	Trazodone Hcl	123	43
Fluoxetine Hcl	Fluoxetine Hcl	122	34
Allopurinol	Allopurinol	120	36
Ozempic	Semaglutide	120	29
Oxybutynin Chloride Er	Oxybutynin Chloride	111	25
Albuterol Sulfate Hfa	Albuterol Sulfate	104	55
Atenolol	Atenolol	94	26
Lovastatin	Lovastatin	88	27
Tamsulosin Hcl	Tamsulosin Hcl	85	29
Clopidogrel	Clopidogrel Bisulfate	84	32
Ciprofloxacin Hcl	Ciprofloxacin Hcl	79	64
Glipizide	Glipizide	79	21
Venlafaxine Hcl Er	Venlafaxine Hcl	75	20
Clonazepam	Clonazepam	72	15
Duloxetine Hcl	Duloxetine Hcl	68	24
Fluticasone Propionate	Fluticasone Propionate	68	30
Jardiance	Empagliflozin	68	14
Metformin Hcl	Metformin Hcl	67	26
Donepezil Hcl	Donepezil Hcl	65	15
Ondansetron Odt	Ondansetron	62	23
Oxycodone Hcl	Oxycodone Hcl	62	22
Bupropion Xl	Bupropion Hcl	61	18
Synthroid	Levothyroxine Sodium	57	17
Lorazepam	Lorazepam	56	21
Acyclovir	Acyclovir	55	22
Estradiol	Estradiol	53	22
Citalopram Hbr	Citalopram Hydrobromide	52	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	13
Carvedilol	Carvedilol	50	22
Paroxetine Hcl	Paroxetine Hcl	50	13
Famotidine	Famotidine	48	18
Quetiapine Fumarate	Quetiapine Fumarate	48	suppressed
Ropinirole Hcl	Ropinirole Hcl	48	11
Eszopiclone	Eszopiclone	47	suppressed
Ipratropium Bromide	Ipratropium Bromide	44	15
Mirtazapine	Mirtazapine	44	13
Montelukast Sodium	Montelukast Sodium	44	18
Amitriptyline Hcl	Amitriptyline Hcl	43	13
Glipizide Er	Glipizide	43	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	43	14
Finasteride	Finasteride	41	15
Methocarbamol	Methocarbamol	41	suppressed
Valacyclovir	Valacyclovir Hcl	41	21
Ezetimibe	Ezetimibe	40	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	11
Paxlovid	Nirmatrelvir/Ritonavir	38	37
Prednisone	Prednisone	37	19
Ibandronate Sodium	Ibandronate Sodium	35	14
Torsemide	Torsemide	35	13
Trulicity	Dulaglutide	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Azithromycin	Azithromycin	33	32
Rizatriptan	Rizatriptan Benzoate	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	18
Baclofen	Baclofen	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	13
Mounjaro	Tirzepatide	29	suppressed
Spironolactone	Spironolactone	29	12
Metoclopramide Hcl	Metoclopramide Hcl	28	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	17
Morphine Sulfate	Morphine Sulfate	26	suppressed
Nitroglycerin	Nitroglycerin	26	14
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	23	suppressed
Nystatin	Nystatin	23	11
Primidone	Primidone	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	12
Advair Hfa	Fluticasone Propion/Salmeterol	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	suppressed
Pregabalin	Pregabalin	20	suppressed
Armour Thyroid	Thyroid,pork	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Gemfibrozil	Gemfibrozil	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Topiramate	Topiramate	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Fentanyl	Fentanyl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Cefuroxime	Cefuroxime Axetil	16	15
Cilostazol	Cilostazol	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Fluocinonide	Fluocinonide	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Nyamyc	Nystatin	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Calcipotriene	Calcipotriene	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Lactulose	Lactulose	11	suppressed
Levocarnitine	Levocarnitine	11	suppressed
Lithium Carbonate	Lithium Carbonate	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Zaleplon	Zaleplon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error